Close Menu

    Closings

    Facebook X (Twitter) Instagram
    • Personalities/Staff
    • Jobs
    • Calendar
    • Contest Rules
    • Contact Us
    • Privacy Policy
    • Login
    RSS Facebook X (Twitter)
    News Radio KMAN
    • Local/State News
      • Manhattan
      • Wamego
      • Riley County
      • Pottawatomie County
      • Fort Riley
      • Geary County
      • State News
      • RCPD Reports
    • Weather
    • Sports
      • K-State Sports
      • High School Sports
        • HS Basketball Schedule & Scores
          • Manhattan High
          • Wamego
          • Rock Creek
          • Riley County
          • Frankfort
          • Blue Valley High
      • Scoreboard Saturday
      • Student-Athlete of the Week
    • Podcasts
      • Within Reason with Mike Matson
      • The Game
      • Wildcat Insider
      • Scoreboard Saturday
    • Obituaries
    • Message Us
      • Birthday/Anniversary
    • Keep It Local
    Listen
    Closings And Delaystyle=
    News Radio KMAN
    You are at:Home»Local News»Scorpius CEO acknowledges agreement with state to build Manhattan facility is no more

    Scorpius CEO acknowledges agreement with state to build Manhattan facility is no more

    0
    By KMAN Staff on January 24, 2025 Local News, Manhattan

    By Rose Gruenbacher

    Scorpius BioManufacturing officials on Thursday told The Mercury the original deal they made with the state to construct a $650-million, 500,000-square-foot vaccine and biologic medicine plant is off after they failed to meet an end-of-year timeline, though they said the door is open to renegotiate a new agreement.

    “I think there’s a desire on everyone’s part to see this happen,” said Scorpius founder and CEO Jeff Wolf in a phone interview. “But you know, I think given the amount of time that it’s taking, the original deal with the state is no more.”

    In April 2022, Scorpius, a San Antonio-based company specializing in emerging biotech and academic research, announced it would build the plant on U.S. Highway 24 east of Manhattan, creating around 500 jobs. Since then, there has been virtually no progress, though state and local officials had reaffirmed the project still would happen.

    To view the full article visit theMercury.com.

    Click here for more local news.

    biological manufacturing facility biotech industry setbacks biotech plant incentives Kansas biotech Kansas job creation Manhattan City Commission Manhattan economic development Manhattan vaccine plant Scorpius BioManufacturing Scorpius deal with state Scorpius plant plans
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    KMAN Staff
    • Website
    • Facebook
    • X (Twitter)

    Related Posts

    Bobian appeals conviction for 2023 murder of wife

    Police board continues to debate 2026 budget

    Manhattan woman and two others hurt in crash near Milford State Park

    Listen Live Here
    Listen Live - Mobile

    Categories

    EEO Report

    FCC Public File

    FCC Applications


    Follow @1350kman on Twitter · Manhattan Broadcasting Company is an equal opportunity employer.
    Manhattan Broadcasting does not discriminate in sale of advertising on the basis of race, gender, or ethnicity, and will not accept advertising which does so discriminate. © 2024 Manhattan Broadcasting Company.

    Follow @1350kman on Twitter · Manhattan Broadcasting Company is an equal opportunity employer.
    Manhattan Broadcasting does not discriminate in sale of advertising on the basis of race, gender, or ethnicity, and will not accept advertising which does so discriminate. © 2024 Manhattan Broadcasting Company.

    Type above and press Enter to search. Press Esc to cancel.

    x